Picture of Sumitomo Pharma Co logo

4506 Sumitomo Pharma Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Sumitomo Pharma Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line48,62735,91836,82940,600-96,714
Depreciation
Non-Cash Items33,18428,86952,19749,85087,168
Unusual Items
Other Non-Cash Items
Changes in Working Capital-47,076-36,02423,902-97,559-20,915
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities48,71146,128135,60131,23910,802
Capital Expenditures-12,914-13,351-10,806-13,494-12,742
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-22,135-299,33319,681-4,78465,161
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-35,049-312,6848,875-18,27852,419
Financing Cash Flow Items-4-1,353-17,335-870-197,436
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-28,645231,081-57,215-21,426-146,817
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-10,479-35,58891,9909,286-59,506